Fintel reports that on December 17, 2024, Morgan Stanley upgraded their outlook for Quest Diagnostics (NYSE:DGX) from ...

Morgan Stanley upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight with a price target of $172, up from $145. The firm sees ...

Shares of Quest Diagnostics Inc. DGX slipped 0.69% to $155.00 Friday, on what proved to be an all-around mixed trading ...

BofA raised the firm’s price target on Quest Diagnostics (DGX) to $182 from $179 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed again in FY24 as Pharma and Biotech ...

Quest Diagnostics Inc. closed $9.25 below its 52-week high ($165.32), which the company achieved on November 25th.

I and my wife have been using Quest Diagnostics for many years and have classified their services as stellar. Well organized, punctual and patient focused. I have also used the online app for as ...

Looking to get into virtual reality? Meta Quest 3 represents a significant step forward in virtual reality (VR) and a great starting point for everyone. The newly unveiled Meta Quest 3S also ...

A draw in the third Test between Australia and India has spiced up the race to the World Test Championship Final. Australia and India continue to play catch-up with South Africa after the ...

After finally building the type of platform required to belatedly seize control in this series, the hosts steadily reverted to type on the opening day of the third test at Seddon Park. Playing to ...